Browsing Tag
SV Health Investors
1 post
AdvanCell strengthens cancer drug pipeline with $112m Series C funding
AdvanCell, a clinical-stage radiopharmaceutical company specializing in targeted alpha therapy, has successfully completed an oversubscribed $112 million Series…